Toxin-Antitoxin Systems of Staphylococcus aureus.

Area of Science:

• Microbiology
• Molecular Biology
• Genetics

Background:

• Toxin-antitoxin (TA) systems are prokaryotic genetic elements encoding toxins that inhibit cellular functions, countered by antitoxins.
• TA systems are classified into six types based on antitoxin nature and toxin regulation.
• Staphylococcus aureus harbors TA types I, II, and III, including MazEF, YefM-YoeB, and omega/epsilon/zeta systems.

Purpose of the Study:

• To investigate the role of TA systems in Staphylococcus aureus pathophysiology.
• To identify potential druggable targets within TA systems.
• To explore the potential of TA systems as a source for novel drug discovery.

Main Methods:

• Identification and characterization of TA systems in S. aureus.
• In silico analysis of TA systems involving toxin-protein and antitoxin-RNA interactions.
• Modification of a staphylococcal TA toxin into a cyclopeptide antibiotic.

Main Results:

• MazF toxin is a sequence-specific RNase targeting transcripts, including pathogenicity factors.
• Two YefM-YoeB paralogs function as independent, autoregulated TA systems producing ribosome-dependent RNases.
• Omega/epsilon/zeta is a tripartite TA system potentially stabilizing resistance factors.
• SprA1/SprA1AS and SprF1/SprG1 systems are regulated by RNA antitoxins and produce membrane-damaging proteins.
• In silico evidence suggests TA systems regulated by toxin-protein and antitoxin-RNA interactions exist in S. aureus.

Conclusions:

• TA systems in S. aureus are implicated in bacterial pathophysiology.
• TA systems represent promising druggable targets for therapeutic intervention.
• Staphylococcal TA toxins can be repurposed as a source for novel drug development, exemplified by cyclopeptide antibiotics.